MRNA vs SXI · rev $145.0M vs P/E 35, rev $891.6M
Moderna Inc (MRNA) versus Standex International Corporation (SXI) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Standex International Corporation (SXI) is a specialty industrial machinery company listed on US.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported SXI revenue for 2026-06-30 was $891.6M. Net income was $104.6M. Revenue was up 12.8% from 2025-06-30 to 2026-06-30. SXI currently screens at market cap $3.52B and trailing P/E 35.3.
MRNA currently screens at market cap $24.52B. SXI currently screens at market cap $3.52B and trailing P/E 35.3.
Not investment advice. Open the MRNA and SXI stock pages for the full models.
Not investment advice.